North America Mice Based Custom Antibody Market Size & Outlook

The mice based custom antibody market in North America is expected to reach a projected revenue of US$ 52.1 million by 2030. A compound annual growth rate of 9.6% is expected of North America mice based custom antibody market from 2024 to 2030.
Revenue, 2023 (US$M)
$27.4
Forecast, 2030 (US$M)
$52.1
CAGR, 2024 - 2030
9.6%
Report Coverage
North America

North America mice based custom antibody market, 2018-2030 (US$M)

North

North America mice based custom antibody market highlights

  • An overview of the North America mice based custom antibody market trends heading towards 2030. The North America market generated a revenue of USD 27.4 million in 2023.
  • The overall growth of the North America market from 2023 to 2030. The market is expected to grow at a CAGR of 9.6% from 2024 to 2030.
  • A look at the North America market revenues per segment in 2023. In terms of segment, oncology was the largest revenue generating application in 2023.
  • The segment witnessing the fastest revenue growth within the market. Oncology is the most lucrative application segment registering the fastest growth during the forecast period.
  • An overview of North America market per country. Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.

North America data book summary

Market revenue in 2023USD 27.4 million
Market revenue in 2030USD 52.1 million
Growth rate9.6% (CAGR from 2023 to 2030)
Largest segmentOncology
Fastest growing segmentOncology
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOncology, Infectious Diseases, Neurology, Stem Cells, Immunology, Cardiovascular Diseases
Key market players worldwideThermo Fisher Scientific Inc, Abcam PLC, Bio-Rad Laboratories Inc, Kaneka Corp, Labcorp Holdings Inc, Genscript Biotech Corp Class H

Other key industry trends

  • In terms of revenue, North America region accounted for 44.3% of the global mice based custom antibody market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 24.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Mice Based Custom Antibody Market Companies

Name Profile # Employees HQ Website

North America mice based custom antibody market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mice based custom antibody market will help companies and investors design strategic landscapes.


Oncology was the largest segment with a revenue share of 24.09% in 2023. Horizon Databook has segmented the North America mice based custom antibody market based on oncology, infectious diseases, neurology, stem cells, immunology, cardiovascular diseases covering the revenue growth of each sub-segment from 2018 to 2030.


  • North America Mice Based Custom Antibody Application Outlook (Revenue, USD Million, 2018-2030)
    • Oncology
    • Infectious Diseases
    • Neurology
    • Stem Cells
    • Immunology
    • Cardiovascular Diseases
    • Others

Reasons to subscribe to North America mice based custom antibody market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America mice based custom antibody market databook

  • Our clientele includes a mix of mice based custom antibody market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America mice based custom antibody market , including forecasts for subscribers. This continent databook contains high-level insights into North America mice based custom antibody market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America Mice Based Custom Antibody Market Outlook Share, 2023 & 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more